Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: With the USPTO initially invalidating the patent in the Forgent

With the USPTO initially invalidating the patent in the Forgent

posted on Dec 16, 2007 07:26AM

Echo Star case, it would seem easier to argue invalidity in court. What would have happened if the USPTO found the patents to be valid? Would the defense then have argued invalidity or just fought against the infringement charges.

So far, we have not heard from USPTO regarding a decision on the re-exam. If it remains this way through a possible trial.....how strong will the Js defense be against validity without the USPTO behind it?

Just thinking out loud here.....does this make sense or am I missing something?

Laurie

Share
New Message
Please login to post a reply